[HTML][HTML] Cell-cycle therapeutics come of age

M Ingham, GK Schwartz - Journal of Clinical Oncology, 2017 - ncbi.nlm.nih.gov
The ability to sustain unscheduled proliferation is a hallmark of cancer. The normal process
of cell division occurs via the cell cycle, a series of highly regulated steps that are …

[PDF][PDF] Emerging targeted and immune-based therapies in sarcoma

SM Pollack, M Ingham, MB Spraker… - Journal of Clinical …, 2018 - clf1.medpagetoday.com
Soft tissue and bone sarcomas are malignancies of mesenchymal origin, and more than 50
subtypes are defined. For most sarcomas, locally advanced or unresectable disease is still …

Phase I dose-escalation trial of MIW815 (ADU-S100), an intratumoral STING agonist, in patients with advanced/metastatic solid tumors or lymphomas

…, WA Messersmith, RHI Andtbacka, M Ingham… - Clinical Cancer …, 2022 - AACR
Purpose: This phase I study assessed the safety, pharmacokinetics (PKs), and efficacy of
MIW815 (ADU-S100), a novel synthetic cyclic dinucleotide that activates the stimulator of IFN …

[HTML][HTML] Therapeutic advances in leiomyosarcoma

K Lacuna, S Bose, M Ingham, G Schwartz - Frontiers in Oncology, 2023 - frontiersin.org
Leiomyosarcoma is an aggressive mesenchymal malignancy and represents one of the
most common subtypes of soft tissue sarcomas. It is characterized by significant disease …

[PDF][PDF] Dissecting the treatment-naive ecosystem of human melanoma brain metastasis

…, M Chazotte, S Berhe, AM Luoma, J Driver, M Ingham… - Cell, 2022 - cell.com
Melanoma brain metastasis (MBM) frequently occurs in patients with advanced melanoma;
yet, our understanding of the underlying salient biology is rudimentary. Here, we performed …

Model-based programming of intelligent embedded systems and robotic space explorers

BC Williams, MD Ingham, SH Chung… - Proceedings of the …, 2003 - ieeexplore.ieee.org
Programming complex embedded systems involves reasoning through intricate system
interactions along lengthy paths between sensors, actuators, and control processors. This is …

A community-sourced glossary of open scholarship terms

…, S Ashcroft-Jones, H Hartmann, M Ingham… - Nature human …, 2022 - nature.com
Open scholarship has transformed research, and introduced a host of new terms in the
lexicon of researchers. The 'Framework for Open and Reproducible Research …

Preliminary results of the first-in-human (FIH) study of MK-1454, an agonist of stimulator of interferon genes (STING), as monotherapy or in combination with …

KJ Harrington, J Brody, M Ingham… - Annals of …, 2018 - annalsofoncology.org
Background: The STING pathway has been implicated in antitumor immunity and response
to immune checkpoint inhibitors. Intratumoral (IT) administration of MK-1454, a cyclic …

Proteomic profiling of human plasma exosomes identifies PPARγ as an exosome-associated protein

C Looze, D Yui, L Leung, M Ingham, M Kaler… - Biochemical and …, 2009 - Elsevier
Exosomes are nanovesicles that are released from cells as a mechanism of cell-free
intercellular communication. Only a limited number of proteins have been identified from the …

Global analysis of in vivo Foxa2-binding sites in mouse adult liver using massively parallel sequencing

…, YJ Zhao, T Zeng, B Bernier, M Ingham… - Nucleic acids …, 2008 - academic.oup.com
Abstract Foxa2 (HNF3β) is a one of three, closely related transcription factors that are critical
to the development and function of the mouse liver. We have used chromatin …